Literature DB >> 8914255

Persistent infection of C3H/HeJ mice by Ehrlichia chaffeensis.

S R Telford1, J E Dawson.   

Abstract

Description of the pathobiology of the recently described zoonotic agent of human ehrlichiosis (Ehrlichia chaffeensis) would be greatly facilitated by the availability of a convenient experimental animal model of infection. We determined whether C3H/HeJ mice could sustain persistent infection by this predominantly monocyte-inhabiting rickettsia. Such mice rapidly produced an intense specific IgG response upon inoculation of ehrlichiae, and high titers were demonstrable for more than 6 months thereafter. Ehrlichiae were reisolated from the peripheral blood and spleen of 1 mouse at day 11 after inoculation. DNA of E. chaffeensis was more frequently detected within these tissues by polymerase chain reaction. Other candidate rodent models appeared to be poor hosts for this pathogen. About half of intact and virtually all splenectomized white-footed mice that were inoculated seroconverted. Sera from inoculated voles and hamsters did not react to antigens of E. chaffeensis. The C3H/Hej mouse becomes persistently infected by this rickettsia, and may serve as a useful model for studies of the immune response to the agent of human ehrlichiosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8914255     DOI: 10.1016/0378-1135(96)00064-8

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  16 in total

1.  Antibody-mediated elimination of the obligate intracellular bacterial pathogen Ehrlichia chaffeensis during active infection.

Authors:  G M Winslow; E Yager; K Shilo; E Volk; A Reilly; F K Chu
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Ehrlichia chaffeensis induces monocyte inflammatory responses through MyD88, ERK, and NF-κB but not through TRIF, interleukin-1 receptor 1 (IL-1R1)/IL-18R1, or toll-like receptors.

Authors:  Koshiro Miura; Junji Matsuo; M Akhlakur Rahman; Yumi Kumagai; Xin Li; Yasuko Rikihisa
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

3.  Animal model of fatal human monocytotropic ehrlichiosis.

Authors:  E A Sotomayor; V L Popov; H M Feng; D H Walker; J P Olano
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 4.  Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum.

Authors:  Yasuko Rikihisa
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

5.  Persistent Ehrlichia chaffeensis infection occurs in the absence of functional major histocompatibility complex class II genes.

Authors:  Roman Reddy Ganta; Melinda J Wilkerson; Chuanmin Cheng; Aaron M Rokey; Stephen K Chapes
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

6.  Antigenic variation of Anaplasma marginale: major surface protein 2 diversity during cyclic transmission between ticks and cattle.

Authors:  A F Barbet; J Yi; A Lundgren; B R McEwen; E F Blouin; K M Kocan
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

7.  Delayed clearance of Ehrlichia chaffeensis infection in CD4+ T-cell knockout mice.

Authors:  Roman R Ganta; Chuanmin Cheng; Melinda J Wilkerson; Stephen K Chapes
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  Histologic, serologic, and molecular analysis of persistent ehrlichiosis in a murine model.

Authors:  Juan P Olano; Gary Wen; Hui-Min Feng; Jere W McBride; David H Walker
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

9.  Naturally occurring Ehrlichia chaffeensis infection in coyotes from Oklahoma.

Authors:  A A Kocan; G C Levesque; L C Whitworth; G L Murphy; S A Ewing; R W Barker
Journal:  Emerg Infect Dis       Date:  2000 Sep-Oct       Impact factor: 6.883

10.  Ehrlichia chaffeensis infections in Drosophila melanogaster.

Authors:  Alison Luce-Fedrow; Tonia Von Ohlen; Stephen K Chapes
Journal:  Infect Immun       Date:  2009-08-17       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.